Wegovy maker Novo shares slump as management grilled
Novo Nordisk shares fell up to 9% after its capital markets day, as investors found its growth plans underwhelming amid competition from Eli Lilly and looming patent expirations.

This headline comes from the wire. Read the full story at the original publisher:
Continue reading at Reuters →



